EUVIMEDEUVIMED entdecken
Crossref

OnabotulinumtoxinA for Pediatric Migraine

Victoria Karian, Hannah Morton, Zoë J Schefter, Allison Smith, Hannah Rogan, Brenna Morse, Alyssa LeBel

Pain Management Nursing · 2023

DOI: 10.1016/j.pmn.2023.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pain Management Nursing, 2023. Verfasst von Victoria Karian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Headache Program, Division of Pain Medicine, Department of Anesthesiology, Perioperative & Pain Medicine, Boston Children's Hospital, Bosto…. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Migraine Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Migraine is a painful, prevalent, and problematic condition among children. Children need access to safe and effective treatment options to alleviate the impact of this chronic condition on their wellbeing. CLINICAL IMPLICATIONS: Nurses have a crucial role in supporting patient access to BTX-A. Given the results of this and other studies demonstrating the safety and efficacy of BTX-A in children, nurses can support policy change for health plans to fund this intervention for pediatric migraineurs. Allowing children to receive the safe and effective BTX-A injections will lessen the already significant impact of chronic migraine on their physical, emotional and mental health. Nurses can also play a key role in providing education to patients regarding safe administration of BTX-A for migraine. AIM: The objective of this study was to define the experiences, effects, and clinical response of children to onabotulinumtoxinA (BTX-A) for migraine prevention. METHODS: Clinical documentation for patients aged 13-17 years presenting for BTX-A treatment for chronic migraine between 2016-2022 in a community-based specialty clinic within a large, urban, pediatric academic medical center were included. A series of one-way repeated measures (analysis of variance [ANOVA]) were conducted to compare headache frequency, severity, and duration at baseline, and following first and second injections of BTX-A. RESULTS: Of 32 eligible participants, administration of BTX-A demonstrated a decrease in headache frequency and severity. Participants reported nearly seven fewer headache days per month. Participants reported neck stiffness, fever or flu-like symptoms, fatigue, and worsening pain following BTX-A administration. CONCLUSIONS: Pediatric migraineurs need therapies that are safe, effective, and accessible. BTX-A was a safe and effective treatment for migraine among the children included in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AMigraine DisordersHumansChildTreatment OutcomePainHeadacheChronic Disease

Substanzen

Botulinum Toxins, Type A

Autor:innen und Institutionen

  • Pediatric Headache Program, Division of Pain Medicine, Department of Anesthesiology, Perioperative & Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Pediatric Headache Program, Division of Pain Medicine, Department of Anesthesiology, Perioperative & Pain Medicine, Boston Children's Hospital, Boston, Massachusetts; School of Nursing, MGH Institute of Health Professio…
  • Pediatric Headache Program, Division of Pain Medicine, Department of Anesthesiology, Perioperative & Pain Medicine, Boston Children's Hospital, Boston, Massachusetts; Department of Anesthesia, Harvard Medical School, Bo…

Zitieren

APA

Karian, V., Morton, H., Schefter, Z. J., Smith, A., Rogan, H., Morse, B., & LeBel, A. (2023). OnabotulinumtoxinA for Pediatric Migraine. Pain Management Nursing. https://doi.org/10.1016/j.pmn.2023.04.006

Vancouver

Karian V, Morton H, Schefter ZJ, Smith A, Rogan H, Morse B, et al. OnabotulinumtoxinA for Pediatric Migraine. Pain Management Nursing. 2023. doi:10.1016/j.pmn.2023.04.006

BibTeX
@article{Karian2023,
  author = {Karian, Victoria and Morton, Hannah and Schefter, Zoë J and Smith, Allison and Rogan, Hannah and Morse, Brenna and LeBel, Alyssa},
  title = {OnabotulinumtoxinA for Pediatric Migraine},
  journal = {Pain Management Nursing},
  year = {2023},
  doi = {10.1016/j.pmn.2023.04.006}
}
Kostenlos starten →